A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease

Clinical trial NCT06826612 · RECRUITING

Trial details

NCT number: NCT06826612
Sponsor: Hoffmann-La Roche
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2025-02-21
Primary completion: 2035-01-12
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.